3rd Quarter - Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$1,560,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues related to patent reform legislation (S. 515; HR 1260).

LobbyistCovered position, as disclosed
LAURIE MICHEL —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 515 (111th), H.R. 1260 (111th)

Budget/Appropriations BUD

Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill).

LobbyistCovered position, as disclosed
LAURIE MICHEL —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to deferral of taxation of foreign earned income and corporate taxation (no specific bill). Issues related to end use of derivatives (no specific bill). Support S. 1203, H.R. 422.

LobbyistCovered position, as disclosed
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 1203 (111th), H.R. 422 (111th)

Health Issues HCR

Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
ERIN DARLING —
ANNE ESPOSITO —
JANE HORVATH —
ELI JOSEPH Leg. Ass't. White House Office of Leg. Affs.
LAURIE MICHEL —
JASON BENJAMIN VAN PELT —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), S. 1679 (111th), S. 301 (111th), S. 1213 (111th)

Medicare/Medicaid MMM

Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; America's Healthy Futures Act of 2009). Oppose expansion of or increase in Medicaid rebate (HR 3200; American's Healthy Futures Act of 2009).

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
ANNE ESPOSITO —
JANE HORVATH —
ELI JOSEPH Leg. Asst. White House Off. of Leg. Affs.
LAURIE MICHEL —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 3200 (111th)

Medical/Disease Research/Clinical Labs MED

Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).

LobbyistCovered position, as disclosed
ERIN DARLING —
ELI JOSEPH Leg. Ass't. White House Off. of Leg. Affairs
LAURIE MICHEL —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 726 (111th), S. 1679 (111th), H.R. 3200 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.